Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
MA12.08 Chemotherapy plus EGFR TKIs or Bevacizumab versus Chemotherapy Alone in SCLC-Transformed EGFR-Mutant Lung Adenocarcinoma
PaperCitations, authors & open-access status
MA12.08 Chemotherapy plus EGFR TKIs or Bevacizumab versus Chemotherapy Alone in SCLC-Transformed EGFR-Mutant Lung Adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 7 citations, 2021 year and closed oa status.
7
Citations
2021
Year
closed
OA Status